Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication

ABSTRACT: Emerging and re-emerging viruses pose a significant threat to global health. Although direct-acting antivirals have shown success, their efficacy is limited by the rapid emergence of drug-resistant viral variants. Hence, there is an urgent need for additional broad spectrum antiviral therapeutic strategies. Here, we identify by phenotypic screening a set of stereochemically defined photoreactive small molecules (photo-stereoprobes) that stereoselectively suppress SARS-CoV-2 replication in human lung epithelial cells. Structure-activity relationship-guided chemical proteomics identified the eukaryotic translation termination factor 1 (ETF1) as a target of the photo-stereoprobes, and this interaction was recapitulated with recombinant purified ETF1. We found that the photo-stereoprobes modulate programmed ribosomal frameshifting mechanisms essential for SARS-CoV-2 infection without causing ETF1 degradation, thus distinguishing the photo-stereoprobes from other known ETF1-directed small molecules. We finally show that the photo-stereoprobes also inhibit the replication of additional viruses with non-canonical ribosomal frameshifting mechanisms. Our findings thus identify a mechanistically distinct class of ETF1 ligands that implicate host translation termination processes as a potential target for antiviral development.

INSTRUMENT(S):

ORGANISM(S): Influenza A Virus Homo Sapiens (human) Severe Acute Respiratory Syndrome Coronavirus 2 Alphavirus Mammarenavirus

TISSUE(S): Lung, Epithelial Cell

DISEASE(S): Human Immunodeficiency Virus Infectious Disease

SUBMITTER: Arthur Kim  

LAB HEAD: Benjamin F. Cravatt

PROVIDER: PXD067975 | Pride | 2026-01-29

REPOSITORIES: pride